CCM
TMDX icon

CAAS Capital Management’s Transmedics TMDX Stock Holding History

CAAS Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-56,885
Closed -$1.02M – 608
2020
Q2 		$1.02M Buy
+56,885
New +$890K 0.03% 266

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

CAAS Capital Management's TMDX Position: Q3 2020 in Review

CAAS Capital Management sold out of Transmedics (TMDX) in Q3 2020, closing a stake of 56,885 shares — an estimated $1.02M sold.

CAAS Capital Management first reported a position in TMDX in Q2 2020 and held it in 1 quarter. The position peaked at $1.02M in Q2 2020. 73 funds tracked by Wall St. Rank hold TMDX as of Q3 2020.

  • CAAS Capital Management reported no remaining Transmedics position as of Q3 2020 after selling out during the quarter.
  • CAAS Capital Management sold 56,885 Transmedics shares in Q3 2020, an estimated $1.02M.
  • CAAS Capital Management first reported a position in Transmedics in Q2 2020 and held it in 1 quarter.
  • CAAS Capital Management's Transmedics position peaked at $1.02M in Q2 2020.
  • 73 funds tracked by Wall St. Rank held Transmedics as of Q3 2020.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.